Skip to main content
Caplight Logo









Boston Pharmaceuticals

Boston Pharmaceuticals

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.bostonpharmaceuticals.com/

Last Round

Corporate Funding

Nov 19, 2015

Total Funding Raised

$600M

Company Overview

Boston Pharmaceuticals is a biopharmaceutical company that acquires and develops clinical-stage therapeutic assets to address unmet medical needs in serious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticaldrug developmentclinical-stagetherapeutic assetsdrug licensingbiotechclinical trialssteatohepatitisMASHasset acquisitionliver diseaseFGF21 analogdrug pipelineout-licensingbiotech incubator

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Boston Pharmaceuticals Comparables

Compare Boston Pharmaceuticals with similar companies based on industry and business-model similarity.

Boston Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Roche Holding
88%
Novo Nordisk
84%
Viking Therapeutics, Inc.
76%

Boston Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingNov 19, 2015

Boston Pharmaceuticals Investors

Notable investors and investment history

Boston Pharmaceuticals investors
InvestorRounds
Gurnet Point CapitalCorporate Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 3, 2026

    Monthly visitors increased 60% MoM.

  • May 4, 2025

    Monthly visitors increased 138% MoM, reaching 3.8K.

Boston Pharmaceuticals Filings

Explore SEC and related filing metadata, where available.

Boston Pharmaceuticals filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Boston Pharmaceuticals's valuation, stock price, and market status.

Is Boston Pharmaceuticals a public or private company?

Boston Pharmaceuticals is a private company.

What is the current stock price of Boston Pharmaceuticals?

Boston Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.

How much is Boston Pharmaceuticals worth (valuation)?

Valuation information for Boston Pharmaceuticals is not publicly available.

Can I buy Boston Pharmaceuticals stock?

Boston Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Boston Pharmaceuticals's last funding round?

Boston Pharmaceuticals's most recent funding round was Corporate Funding on November 19, 2015.

Who are the main investors in Boston Pharmaceuticals?

Key investors in Boston Pharmaceuticals include Gurnet Point Capital.

Will Boston Pharmaceuticals IPO soon?

No public IPO plans have been announced for Boston Pharmaceuticals.

How can I track Boston Pharmaceuticals secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Boston Pharmaceuticals's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range34
Year Founded2015
Last FundingNov 19, 2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?